FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17521511000001106: Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60552101000001110 Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111504801000001113 Tranexamic acid 500mg tablets (Advanz Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) Is a Product containing precisely tranexamic acid 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) Has active ingredient Tranexamic acid false Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) Has specific active ingredient Tranexamic acid true Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) 60 tablet Has AMP True Tranexamic acid 500mg tablets (Goldshield Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start